Skip to main content
Top
Published in: Supportive Care in Cancer 8/2008

01-08-2008 | Short Communiation

Peritoneal catheter for continuous drainage of ascites in advanced cancer patients

Authors: Sebastiano Mercadante, Giuseppe Intravaia, Patrizia Ferrera, Patrizia Villari, Fabrizio David

Published in: Supportive Care in Cancer | Issue 8/2008

Login to get access

Abstract

Introduction

Advanced cancer patients with refractory ascites do not often respond to dietary sodium restriction and diuretics. While paracentesis is effective, the condition invariably recurs, necessitating repeated procedures. A continuous peritoneal drainage by an indwelling catheter has been reported to be hugely beneficial symptomatically, avoiding the hazards and disadvantages of multiple repeated procedures and direct and indirect costs.

Materials and methods

Forty patients with advanced cancer patients admitted to an acute pain relief and palliative care unit, who presented symptomatic ascites, were recruited for continuous drainage of peritoneal fluid. A central venous catheter set for Seldinger technique was used. Technical failure was defined as an unsuccessful drainage of fluid through the catheter. Immediate and late complications, including hypotension, haemorrhage, tube blockage, dislodgment and sepsis were recorded. Record of daily drainage during admission were noted. At time of discharge, patients were asked to rate their global symptom burden as improved, unchanged or worsened. The follow-up was performed with frequent phone contacts or day-hospital admission in case of problems.

Results

The mean patients’ age was 68 years, and 21 were men. Patients were receiving unsuccessfully a mean dose of furosemide of 32 mg/day. The technique was not painful and was easily accepted by patients. Insertion was technically successful in almost all patients. Mean admission time was 5.5 days (range 2–14), and the mean drained volume during admission was 8,499 ml (range 800–20,700), 2,850 ml (300–4,200) being drained on the first 24 h. No immediate complications were recorded. Six patients died during admission. The mean survival was 38.9 days (range 1–120). Of the 34 patients who were discharged home, 22 patients stated that symptom burden had improved, while in 10 patients symptom burden did not change or worsened, probably due to the advanced status of diseases and multiple contributing factors. Five, two, and one patients required skin sutures at 1, 2 and 3 months, respectively. About one third of patients had mechanical problems, some of them requiring a catheter replacement. No infection was recorded.

Conclusion

In conclusion, a permanent peritoneal catheter was a valuable method to remove abdominal fluids and reduce symptom burden attributable to ascites and was also easy to use at home. Complication rate was acceptable and balanced by the benefits of the technique which avoided frequent paracentesis and associated complications.
Literature
1.
go back to reference Becker G, Galandi D, Blum HE (2006) Malignant ascites: systematic review and guideline treatment. Eur J Cancer 42:589–597PubMedCrossRef Becker G, Galandi D, Blum HE (2006) Malignant ascites: systematic review and guideline treatment. Eur J Cancer 42:589–597PubMedCrossRef
2.
go back to reference Belfort MA, Stevens PJ, DeHaek K, Soeters R, Krige JE (1990) A new approach to the management of malignant ascites: a permanent implanted abdominal drain. Eur J Surg Oncol 16:47–53PubMed Belfort MA, Stevens PJ, DeHaek K, Soeters R, Krige JE (1990) A new approach to the management of malignant ascites: a permanent implanted abdominal drain. Eur J Surg Oncol 16:47–53PubMed
3.
go back to reference Bui CDH, Martin CJ, Currow DC (1999) Effective community palliation of intractable malignant ascites ith a permanently implanted abdominal drain. J Palliat Med 2:319–312PubMedCrossRef Bui CDH, Martin CJ, Currow DC (1999) Effective community palliation of intractable malignant ascites ith a permanently implanted abdominal drain. J Palliat Med 2:319–312PubMedCrossRef
4.
go back to reference Lee A, Lau TN, Yeong KY (2000) Indwelling catheters for the management of malignant ascies. Support Care cancer 8:493–499PubMed Lee A, Lau TN, Yeong KY (2000) Indwelling catheters for the management of malignant ascies. Support Care cancer 8:493–499PubMed
5.
go back to reference MacDonald R, Kirwan J, Roberts S, Gray D, Allsopp L, Green J (2006) Ovarian cancer and acsites: a questionnaire on current management in the United Kingdom. J Palliat Care 8:1264–1270 MacDonald R, Kirwan J, Roberts S, Gray D, Allsopp L, Green J (2006) Ovarian cancer and acsites: a questionnaire on current management in the United Kingdom. J Palliat Care 8:1264–1270
6.
go back to reference McNamara P (2000) Paracentesis—an effective method of symptom control in the palliative setting? Palliat Med 14:62–64PubMedCrossRef McNamara P (2000) Paracentesis—an effective method of symptom control in the palliative setting? Palliat Med 14:62–64PubMedCrossRef
7.
go back to reference Regnard C, Manix K (1989) Management of ascites in advanced cancer—a flow diagram. Palliat Med 4:45–47CrossRef Regnard C, Manix K (1989) Management of ascites in advanced cancer—a flow diagram. Palliat Med 4:45–47CrossRef
8.
9.
go back to reference Rossle M, ochs A, Guilberg V et al (2000) A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342:1701–1707PubMedCrossRef Rossle M, ochs A, Guilberg V et al (2000) A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342:1701–1707PubMedCrossRef
10.
go back to reference Sabatelli FW, Glassman ML, Kerns SR, Hawkins IF (1994) Permanent indwelling peritoneal access device fort he management of malignant ascites. Cardiovasc Intervent Radiol 17:292–294PubMedCrossRef Sabatelli FW, Glassman ML, Kerns SR, Hawkins IF (1994) Permanent indwelling peritoneal access device fort he management of malignant ascites. Cardiovasc Intervent Radiol 17:292–294PubMedCrossRef
11.
go back to reference Sharma S, Walsh D (1995) Management of symptomatic malignant ascites with diuretics: two case reports and a review of the literature. J Pain Symptom Manage 10:237–242PubMedCrossRef Sharma S, Walsh D (1995) Management of symptomatic malignant ascites with diuretics: two case reports and a review of the literature. J Pain Symptom Manage 10:237–242PubMedCrossRef
12.
go back to reference Stephensen J, Gilbert J (2002) The development of clinical guidelines on paracentesis for ascites related to malignancy. Palliat Med 16:213–218CrossRef Stephensen J, Gilbert J (2002) The development of clinical guidelines on paracentesis for ascites related to malignancy. Palliat Med 16:213–218CrossRef
Metadata
Title
Peritoneal catheter for continuous drainage of ascites in advanced cancer patients
Authors
Sebastiano Mercadante
Giuseppe Intravaia
Patrizia Ferrera
Patrizia Villari
Fabrizio David
Publication date
01-08-2008
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0453-x

Other articles of this Issue 8/2008

Supportive Care in Cancer 8/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine